<?xml version="1.0" encoding="UTF-8"?>
<p>According to the World Health Organization, the prevalence of obesity has been increasing globally [
 <xref rid="B1-pharmaceuticals-13-00056" ref-type="bibr">1</xref>]. In 2017, 2 billion and 650 million people were estimated to be overweight or obese, respectively. Thailand is an example of a country with a growing obese population [
 <xref rid="B2-pharmaceuticals-13-00056" ref-type="bibr">2</xref>]. Thailand has the second largest prevalence of obesity among Southeast Asian countries, and approximately 32% of the population is overweight [
 <xref rid="B3-pharmaceuticals-13-00056" ref-type="bibr">3</xref>]. Several drugs have been developed to treat obesity in conjunction with diet control and exercise [
 <xref rid="B4-pharmaceuticals-13-00056" ref-type="bibr">4</xref>]. Drugs exert positive effects on weight by inhibiting the absorption of lipids from the gastrointestinal tract or reducing food intake through suppressing appetite. However, some of the currently available anti-obesogenic drugs have been withdrawn from the market due to their adverse effects [
 <xref rid="B4-pharmaceuticals-13-00056" ref-type="bibr">4</xref>]. Hence, new drugs are continuously being studied.
</p>
